Fuelling innovation, powering growth
Our long-term vision is for more home-grown and fully funded, high-growth companies to fulfil their potential to be significant players on the global stage.
We will achieve our vision by building a diversified portfolio of best-in-class venture and venture growth funds.
By increasing the availability of patient capital to high-growth businesses, we fuel innovation, heighten ambition and power economic growth.
Future Fund: Breakthrough
£375m co-investment programme for growth stage R&D intensive technology companies
Read more about Future Fund: BreakthroughKey statistics
£2.5bn investment programme
500+ Innovative high-growth companies in our underlying portfolio (As at 31 March 2020)
£1bn+ Total commitments to date (As at 31 March 2020)
TVPI multiple 1.15 (As at 31 March 2020)
Our approach
We target best-in-class venture and venture growth fund managers.
Read more about the approach of British Patient Capital
Partner with us
We look to build long-term relationships.
Read more about what we're looking for in British Patient Capital Partners
Life Sciences Investment Programme
£200m programme for later-stage life science focused funds.
Life Sciences Investment Programme about the Life Sciences Investment Programme
